Pharmaceuticals
-
{
- All
- News
- Videos
-
One QR Scan Can Tell If Your Medicine Is Fake. Here's How It Works
The government has steadily expanded the use of QR codes to make fake medicines harder to introduce into the supply chain.
-
US Turn To Indian Pharmaceuticals Amid Critical Cancer Drug Shortage
US has sought help from Indian pharmaceutical manufacturers to address a shortage of the cancer drug ifosfamide.
-
Jan Aushadhi Kendras Expand Across India From 84 In 2014 To More Than 19,200 In 2026
New Delhi, June 17 (IANS) From around 84 functional Jan Aushadhi Kendras in 2014, the network has grown to more than 19,200 Kendras across the country in 2026, making quality generic medicines accessible at affordable prices to millions of citizens, the government said on Wednesday.
-
EU Secures Emergency Deliveries Of Potential Treatment Against Hantavirus
The European Union is launching emergency procurement procedures to secure additional doses in case further hantavirus cases are confirmed in the coming weeks.
-
Fake Mounjaro In India: Eli Lilly Issues Tips And Checklist To Identify Fakes
In a significant move to protect consumers, the Haryana State-FDA recently conducted a successful operation in Gurugram, seizing counterfeit products falsely labelled as Mounjaro (tirzepatide).
-
Fake Mounjaro In India: Eli Lilly Issues Tips And Checklist To Identify Fakes
In a significant move to protect consumers, the Haryana State-FDA recently conducted a successful operation in Gurugram, seizing counterfeit products falsely labelled as Mounjaro (tirzepatide).
-
US, Israeli Strikes Hit Iranian Company Producing Cancer Drugs
One of the largest companies producing anti-cancer, anaesthetic and specialised medicines was damaged in US-Israeli strikes, Iran claims in an X post.
-
India Pharmaceutical Sector Aims To Make India A Global Innovation Hub In 2026
New Delhi, March 30 (IANS) India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based growth to value and rese
-
India Pharmaceutical Sector Aims To Make India A Global Innovation Hub In 2026
New Delhi, March 30 (IANS) India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based growth to value and rese
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
Health Ministry Amends Rules To Ease Drug Research, Cut Regulatory Delays By 90 Days
The Union Health Ministry has amended the NDCT Rules, 2019 to reduce regulatory burden, waive permissions for low-risk studies, and speed up drug development timelines by at least 90 days, boosting pharmaceutical R&D in India.
-
Health Ministry Amends Rules To Ease Drug Research, Cut Regulatory Delays By 90 Days
The Union Health Ministry has amended the NDCT Rules, 2019 to reduce regulatory burden, waive permissions for low-risk studies, and speed up drug development timelines by at least 90 days, boosting pharmaceutical R&D in India.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Hyderabad-Based Pharmaceutical Gets US Nod For Generic ADHD Drug: Why This Matters And What It Means
ADHD is a neurodevelopmental condition that affects both children and adults. It is characterised by symptoms such as difficulty concentrating, impulsive behaviour and hyperactivity.
-
One QR Scan Can Tell If Your Medicine Is Fake. Here's How It Works
The government has steadily expanded the use of QR codes to make fake medicines harder to introduce into the supply chain.
-
US Turn To Indian Pharmaceuticals Amid Critical Cancer Drug Shortage
US has sought help from Indian pharmaceutical manufacturers to address a shortage of the cancer drug ifosfamide.
-
Jan Aushadhi Kendras Expand Across India From 84 In 2014 To More Than 19,200 In 2026
New Delhi, June 17 (IANS) From around 84 functional Jan Aushadhi Kendras in 2014, the network has grown to more than 19,200 Kendras across the country in 2026, making quality generic medicines accessible at affordable prices to millions of citizens, the government said on Wednesday.
-
EU Secures Emergency Deliveries Of Potential Treatment Against Hantavirus
The European Union is launching emergency procurement procedures to secure additional doses in case further hantavirus cases are confirmed in the coming weeks.
-
Fake Mounjaro In India: Eli Lilly Issues Tips And Checklist To Identify Fakes
In a significant move to protect consumers, the Haryana State-FDA recently conducted a successful operation in Gurugram, seizing counterfeit products falsely labelled as Mounjaro (tirzepatide).
-
Fake Mounjaro In India: Eli Lilly Issues Tips And Checklist To Identify Fakes
In a significant move to protect consumers, the Haryana State-FDA recently conducted a successful operation in Gurugram, seizing counterfeit products falsely labelled as Mounjaro (tirzepatide).
-
US, Israeli Strikes Hit Iranian Company Producing Cancer Drugs
One of the largest companies producing anti-cancer, anaesthetic and specialised medicines was damaged in US-Israeli strikes, Iran claims in an X post.
-
India Pharmaceutical Sector Aims To Make India A Global Innovation Hub In 2026
New Delhi, March 30 (IANS) India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based growth to value and rese
-
India Pharmaceutical Sector Aims To Make India A Global Innovation Hub In 2026
New Delhi, March 30 (IANS) India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based growth to value and rese
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
Health Ministry Amends Rules To Ease Drug Research, Cut Regulatory Delays By 90 Days
The Union Health Ministry has amended the NDCT Rules, 2019 to reduce regulatory burden, waive permissions for low-risk studies, and speed up drug development timelines by at least 90 days, boosting pharmaceutical R&D in India.
-
Health Ministry Amends Rules To Ease Drug Research, Cut Regulatory Delays By 90 Days
The Union Health Ministry has amended the NDCT Rules, 2019 to reduce regulatory burden, waive permissions for low-risk studies, and speed up drug development timelines by at least 90 days, boosting pharmaceutical R&D in India.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Hyderabad-Based Pharmaceutical Gets US Nod For Generic ADHD Drug: Why This Matters And What It Means
ADHD is a neurodevelopmental condition that affects both children and adults. It is characterised by symptoms such as difficulty concentrating, impulsive behaviour and hyperactivity.
